Advertisement
Advertisement
Trending on Dermatology Times
1
MAIC Evaluates 1-Year Outcomes of Biologics in HS
2
Phase 2 Data Highlight Roflumilast Cream in Infant AD
3
Narrow-Spectrum Sarecycline Approved for Moderate to Severe Acne in China
4
Del Rosso's What's New in the Medicine Chest 2026: Mastocytosis and Inflammatory Disease
5
